Twitter Facebook LinkedIn

Heat Biologics, Inc. Heat Biologics, Inc.

  • Home
  • About
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Technology
  • Pipeline
    • Overview
    • HS-110
    • HS-130
    • Expanded Access
    • Scientific Publications
  • Investors
  • News & Media
  • Careers
  • Contact

News Releases

Heat Biologics, Inc. to Present at Biotech Showcase 2014

Jan 7, 2014

Heat Biologics Announces Its Phase 1/2 Study of HS-410 in Bladder Cancer Is Open for Enrollment

Dec 30, 2013

Heat Biologics, Inc. Appoints Dr. Anil K. Goyal as Vice President of Business Development

Dec 17, 2013

Heat Biologics, Inc. to Present at 25th Annual Piper Jaffray Healthcare Conference

Dec 2, 2013

Heat Biologics Successfully Completes Manufacturing of HS-410 to Start Phase 1/2 Bladder Cancer Trial

Nov 25, 2013

Heat Biologics, Inc. Reports Third Quarter 2013 Financial Results and Provides Clinical Programs Review

Nov 14, 2013

Heat Biologics, Inc. to Present at 12th Annual BIO Investor Forum

Oct 2, 2013

Heat Biologics Files IND for Bladder Cancer Product Candidate

Oct 1, 2013

Heat Biologics Appoints Louis C. Bock to Board of Directors

Sep 25, 2013

Heat Biologics, Inc. to Present at Aegis Capital Corp. 2013 Healthcare Conference

Sep 19, 2013
    • 1...
    • 20
    • 21
    • 22
    • 23
    • 24
    • 25
    • 26
    • 27
    • 28
    • 29
    NightHawk Biosciences

    OUR ECOSYSTEM

    SkunkWorx Bio
    Heat Biologics
    Elusys Therapeutics Inc.
    Pelican Therapeutics
    Scorpion Biological Services
    © 2022 Heat Biologics, Inc. All Rights Reserved.
    Privacy Policy Disclaimer Sitemap LinkedIn